{
  "id": "3c99a322a4865e33",
  "title": "FDA Accepts sBLA for Ropeginterferon - Alfa - 2b for Essential Thrombocythemia",
  "description": "20260113T204500Z",
  "content": "",
  "source": "onclive.com",
  "source_url": "https://www.onclive.com/view/fda-accepts-sbla-for-ropeginterferon-alfa-2b-for-essential-thrombocythemia",
  "published_at": "20260113T204500Z",
  "fetched_at": "2026-01-14T00:24:05.619157+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.onclive.com/view/fda-accepts-sbla-for-ropeginterferon-alfa-2b-for-essential-thrombocythemia",
    "url_mobile": "",
    "title": "FDA Accepts sBLA for Ropeginterferon - Alfa - 2b for Essential Thrombocythemia",
    "seendate": "20260113T204500Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/onclive/4532fbaebbca96a6a96d9051297abfa19c96ace7-1280x720.jpg",
    "domain": "onclive.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}